Latestarticle

 

Dr. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population, met with his Indian counterpart, Jagat Prakash Nadda, Minister of Health, Chemicals, and Fertilizers, to strengthen bilateral cooperation in the healthcare sector, particularly in exchanging expertise in the pharmaceutical industry and exploring joint investment opportunities between the two countries.

The meeting was held on the sidelines of preparations for the third International Conference on Population, Health, and Development (ICPD) 2025, which will take place under the patronage of President Abdel Fattah El-Sisi from November 12 to 15, 2025, at the St. Regis Hotel in the New Administrative Capital, under the theme: “Empowering People, Promoting Progress, and Creating Opportunities.”

Dr. Hossam Abdel Ghaffar, spokesperson for the Ministry of Health and Population, stated that the Egyptian Minister opened the meeting by highlighting the political leadership’s prioritization of the health sector, especially the pharmaceutical industry, and its commitment to expanding the investment environment in cooperation with leading global partners to enhance efficiency, improve quality, and boost the competitiveness of the Egyptian market.

Dr. Abdel Ghaffar noted that Egypt’s achievements in the pharmaceutical industry were reviewed, with emphasis on the sector’s highly skilled workforce. The two sides discussed expanding partnerships in pharmaceutical manufacturing and healthcare, as well as exploring joint projects between Egyptian and Indian pharmaceutical companies, particularly in the production of oncology medicines. The discussions also focused on technology transfer and localizing the manufacturing of high-tech pharmaceuticals in Egypt.

The meeting also explored opportunities to encourage healthcare investment through strategic agreements in vaccine production, oncology drugs, and biopharmaceuticals. Both sides highlighted the importance of technology transfer and capacity building through specialized training programs and the development of pharmaceutical and healthcare infrastructure.

Additionally, the ministers discussed mechanisms to facilitate pharmaceutical investment by streamlining procedures for drug registration, import, and export. They emphasized the need for coordinated efforts among the public and private sectors, civil society, and pharmaceutical and vaccine manufacturers in both countries to maximize the impact of joint initiatives.

Source: Egypt Today